Eric Groen
Patrimonio netto: 687 834 $ in data 31/07/2026
Patrimonio netto: 687 834 $ in data 31/07/2026
Eric Groen is currently Secretary & Chief Compliance Officer at Genelux Corp.
since 2025.
Formerly, Mr. Groen was Regional General Counsel at Amgen, Inc. and General Counsel at Rani Therapeutics Holdings, Inc. Education includes undergraduate studies at the University of California, Santa Barbara and graduate studies at Harvard Law School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
GENELUX CORP. 0,52% | 16/06/2026 | 233.957 ( 0,52% ) | 687 834 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| GENELUX CORPORATION | Responsabile della Conformità | 01/07/2025 |
| Società | Posizione | Fine |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | - |
| RANI THERAPEUTICS HOLDINGS, INC. | Consigliere Generale | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genelux Corp.
Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Law School
Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale